Willow GLP-1 Review (2026): Pricing, Coverage, and Tradeoffs

Item: Willow
Author: RangeYourself

Willow review, semaglutide compounded, from $299/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). willow's own faq notes cost varies by dosage and prescription, confirm your exact rate in the assessment., tirzepatide compounded glp-1/gip, from $399/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). same dosage-based pricing applies, confirm your exact rate in the assessment.. Compounded GLP-1 shoppers who want a choice between injectable and needle-free sublingual tablets for both semaglutide and tirzepatide, in one of Willow's 36 served states. Independent 2026 review from RangeYourself.

By RangeYourselfLast verified 2026-09-15

Quick take

Willow is compounded glp-1 (semaglutide) and glp-1/gip (tirzepatide), your choice of once-weekly injection or once-daily sublingual tablet; nad+ also offered, priced as cash-pay subscription; semaglutide (injection or tablet) from $299/mo, tirzepatide (injection or tablet) from $399/mo. willow's own faq states medication cost "varies by dosage and prescription," so these are starting prices, not flat rates.. Best for: Compounded GLP-1 shoppers who want a choice between injectable and needle-free sublingual tablets for both semaglutide and tirzepatide, in one of Willow's 36 served states. Watch out for: Willow lists $299/mo (semaglutide) and $399/mo (tirzepatide) as starting prices; its own FAQ states medication cost "varies by dosage and prescription," so confirm your exact recurring rate during the assessment. Willow is available in 36 states, not all 50.

Pricing summary

Price verified: 2026-09-15 (checked against the provider’s public pricing surface)
All-in monthly cost: $299/month (medication included), advertised starting price
Semaglutide: Compounded, from $299/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). Willow's own FAQ notes cost varies by dosage and prescription, confirm your exact rate in the assessment.
Tirzepatide: Compounded GLP-1/GIP, from $399/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). Same dosage-based pricing applies, confirm your exact rate in the assessment.
Compounded vs brand-name: Compounded only
Insurance accepted: No insurance-billing path published (cash-pay); confirm at signup
Consult type: Async questionnaire, per the provider’s published flow
Dose-escalation pricing: Willow's own FAQ states: "Medication costs vary by dosage and prescription. Your doctor will help you choose the plan that fits your goals and lifestyle." The $299 (semaglutide) / $399 (tirzepatide) figures are starting prices, not guaranteed flat rates at every dose.
Refund policy: Cancel anytime by messaging the Patient Care Team. Submit cancellation at least 2 business days before the next processing date to avoid the next charge. A full refund is issued within 5-10 business days if you cancel before your prescription is sent to the pharmacy; requests received after the cutoff apply to the next billing cycle.
States served: 36 states (AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, IA, KY, ME, MD, MA, MI, MN, MO, MT, NE, NV, NH, NJ, NY, NC, OH, OK, OR, PA, SC, TN, TX, VA, WA, WI, WY per Willow's own FAQ), confirm your state at signup

Check Willow pricing →

Choose Willow if

You want a choice between injectable and needle-free sublingual tablets for both semaglutide and tirzepatide
You live in one of the 36 states Willow currently serves
You want FSA/HSA-eligible billing with no separate membership fee
You're comfortable confirming your exact recurring rate in the assessment, since Willow's own FAQ says price varies by dosage

Skip Willow if

You want a single flat price guaranteed at every dose, live outside Willow's current 36 served states, or need insurance billing.

Contraindications and clinical notes

Standard GLP-1 contraindications per semaglutide/tirzepatide prescribing information (personal/family history of medullary thyroid carcinoma or MEN 2). Willow's own eligibility screen excludes patients with diabetes; pre-diabetes and hypertension are accepted.. Talk to a clinician about personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, or other conditions before starting any GLP-1 medication.

Verified programs that cost less than Willow

Willow’s own verified figure is $299/mo (advertised starting price). Every program below carries a lower all-in monthly price that we verified on the provider’s own pricing page, ranked lowest first as of September 21, 2026.

1.Embody
$69/mo (limited-time promo), verified September 17, 2026
See pricing →
2.Strut Health
$99/mo (sublingual/oral starting price), verified August 21, 2026
See pricing →
3.Trimi
$99/mo (annual-plan rate), verified August 21, 2026
See pricing →
4.HealthRX
$99/mo (12-month plan rate), verified September 16, 2026
See pricing →
5.bmiMD
$119/mo (12-month plan rate), verified September 3, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

How Willow compares

Frequently asked questions

How much does Willow cost per month?

Willow's lowest verified rate is $299/month with compounded medication included. Semaglutide: Compounded, from $299/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). Willow's own FAQ notes cost varies by dosage and prescription, confirm your exact rate in the assessment.; tirzepatide: Compounded GLP-1/GIP, from $399/mo, your choice of once-weekly injection or once-daily sublingual tablet (verified 2026-09-15). Same dosage-based pricing applies, confirm your exact rate in the assessment.. Willow's own FAQ states: "Medication costs vary by dosage and prescription. Your doctor will help you choose the plan that fits your goals and lifestyle." The $299 (semaglutide) / $399 (tirzepatide) figures are starting prices, not guaranteed flat rates at every dose.

Does Willow accept insurance?

Willow publishes cash-pay prices and we found no insurance-billing path on its own site. Where a provider's own FAQ leaves the door open, the answer sits inside its intake flow, which we do not enter, so confirm at signup rather than treating this as settled. If you want insurance-billed brand-name GLP-1, see our list of GLP-1 programs that accept insurance.

What states does Willow serve?

Willow serves 36 states (AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, IA, KY, ME, MD, MA, MI, MN, MO, MT, NE, NV, NH, NJ, NY, NC, OH, OK, OR, PA, SC, TN, TX, VA, WA, WI, WY per Willow's own FAQ), confirm your state at signup.

Is Willow compounded or brand-name?

Willow prescribes compounded semaglutide and tirzepatide via state-licensed 503A pharmacies or 503B outsourcing facilities. Compounded medication is not individually FDA-approved. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

What's the catch with Willow?

Willow lists $299/mo (semaglutide) and $399/mo (tirzepatide) as starting prices; its own FAQ states medication cost "varies by dosage and prescription," so confirm your exact recurring rate during the assessment. Willow is available in 36 states, not all 50. Avoid if: you want a single flat price guaranteed at every dose, live outside willow's current 36 served states, or need insurance billing.

Related guides

Willow availability by state

GLP-1 programs in California , where Willow ships and how it stacks up locally.
GLP-1 programs in Texas , where Willow ships and how it stacks up locally.
GLP-1 programs in Florida , where Willow ships and how it stacks up locally.
GLP-1 programs in New York , where Willow ships and how it stacks up locally.
GLP-1 programs in Illinois , where Willow ships and how it stacks up locally.

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

About these products

These are compounded preparations, not FDA-approved for anti-aging or longevity indications, and a prescription from a licensed clinician is required. Compounding pharmacies are not individually reviewed by the FDA for the safety or effectiveness of a specific compounded product. We rank and describe these programs on price and access only, never on efficacy, outcomes, or benefit claims, and we do not repeat a provider’s own marketing claims as independently verified fact.

NAD+: NAD+ is not an FDA-approved drug, and its compounding status is not settled in its favor. In a warning letter to GenoGenix LLC dated January 20, 2026 (WL#718739), the FDA stated that NAD+ is not eligible for compounding by a 503B outsourcing facility. We could not identify a clear 503A pathway for it either: it has no USP monograph and is not a component of an approved drug. A Class I recall of an NAD+ injectable over endotoxin contamination is also on the record. We rank the programs on this page on published price only, and price is not a safety, quality, or eligibility signal here, confirm sourcing, the dispensing pharmacy, and any state restrictions directly with the provider before purchase, and discuss it with a prescribing clinician.

These peptide and longevity products are not identical to, and are never described here as generic or equivalent to, any FDA-approved drug, and unlike compounded GLP-1 medication most of them have no FDA-approved counterpart at all. State availability varies by provider and by product, several programs listed here disclose per-state restrictions; confirm eligibility in your state before purchase. RangeYourself does not provide medical advice and does not guarantee a prescription.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers verified on 2026-09-15 and may change.